Author:
Jordan K.,Jahn F.,Aapro M.
Reference69 articles.
1. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study;Hesketh;Ann Oncol,2014
2. A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy;Aapro;Ann Oncol,2014
3. A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy;Gralla;Ann Oncol,2014
4. Improving the functional status of patients with cancer by more effectively preventing chemotherapy-induced nausea and vomiting (CINV): results of a phase 3 study of NEPA (fixed-dose combination of netupitant and palonosetron);Jahn;Eur J Oncol Nursing,2014
5. et al. Multicycle efficacy and safety of NEPA, a fixed-dose antiemetic combination of netupitant and palonosetron, in patients receiving chemotherapy of varying emetogenicity;Aapro;Ann Oncol,2014
Cited by
161 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献